LENVATINIB IMPROVES PROGRESSION FREE SURVIVAL IN PATIENTS WITH INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA AFTER TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION

被引：0
|
作者：
Shimose, Shigeo [1 ]
Kawaguchi, Takumi [1 ]
Iwamoto, Hideki [1 ]
Nakano, Masahito [1 ]
Takashi, Niizeki [1 ]
Shirono, Tomotake [1 ]
Tanaka, Masatoshi [2 ]
Koga, Hironori [1 ]
Torimura, Takuji [1 ]
机构：
[1] Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, Kurume, Fukuoka, Japan
[2] Yokokura Hosp, Miyama, Fukuoka, Japan
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
367
引用
收藏
页码：233A / 234A
页数：2
相关论文
共 50 条
  • [1] Clinical Effect of Lenvatinib Re-Administration after Transcatheter Arterial Chemoembolization in Patients with Intermediate Stage Hepatocellular Carcinoma
    Mawatari, Seiichi
    Tamai, Tsutomu
    Kumagai, Kotaro
    Saisyoji, Akiko
    Muromachi, Kaori
    Toyodome, Ai
    Taniyama, Ohki
    Sakae, Haruka
    Ijuin, Sho
    Tabu, Kazuaki
    Oda, Kohei
    Hiramine, Yasunari
    Moriuchi, Akihiro
    Sakurai, Kazuhiro
    Kanmura, Shuji
    Ido, Akio
    CANCERS, 2022, 14 (24)
  • [2] Transcatheter arterial chemoembolization plus Sorafenib versus transcatheter arterial chemoembolization plus Lenvatinib for intermediate hepatocellular carcinoma
    Wang, Moxuan
    Cheng, Jiamin
    Qian, Niansong
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [3] Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma
    Ando, Yuwa
    Kawaoka, Tomokazu
    Amioka, Kei
    Naruto, Kensuke
    Ogawa, Yutaro
    Yoshikawa, Yuki
    Kikukawa, Chihiro
    Kosaka, Yumi
    Uchikawa, Shinsuke
    Morio, Kei
    Fujino, Hatsue
    Nakahara, Takashi
    Murakami, Eisuke
    Yamauchi, Masami
    Tsuge, Masataka
    Hiramatsu, Akira
    Fukuhara, Takayuki
    Mori, Nami
    Takaki, Shintaro
    Tsuji, Keiji
    Nonaka, Michihiro
    Hyogo, Hideyuki
    Aisaka, Yasuyuki
    Masaki, Keiichi
    Honda, Yoji
    Moriya, Takashi
    Naeshiro, Noriaki
    Takahashi, Shoichi
    Imamura, Michio
    Chayama, Kazuaki
    Aikata, Hiroshi
    ONCOLOGY, 2021, 99 (08) : 507 - 517
  • [4] Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma
    Nishikawa, Hiroki
    Osaki, Yukio
    Kita, Ryuichi
    Kimura, Toru
    Ohara, Yoshiaki
    Takeda, Haruhiko
    Sakamoto, Azusa
    Saito, Sumio
    Nishijima, Norihiro
    Nasu, Akihiro
    Komekado, Hideyuki
    Nishiguchi, Shuhei
    ONCOLOGY REPORTS, 2014, 31 (01) : 65 - 72
  • [5] Post progression survival in patients with intermediate-stage hepatocellular carcinoma after receiving transarterial chemoembolization
    Shima, Yukiko
    Ogasawara, Sadahisa
    Ooka, Yoshihiko
    Kobayashi, Kazufumi
    Maruta, Susumu
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Maeda, Takahiro
    Kusakabe, Yuko
    Kiyono, Soichiro
    Nakamura, Masato
    Saito, Tomoko
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Yasui, Shin
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Arai, Makoto
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Kato, Naoya
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E75 - E75
  • [6] Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma
    Uchida-Kobayashi, Sawako
    Kageyama, Ken
    Takemura, Shigekazu
    Matsumoto, Kazuhiro
    Odagiri, Naoshi
    Jogo, Atsushi
    Kotani, Kohei
    Kozuka, Ritsuzo
    Motoyama, Hiroyuki
    Kawamura, Etsushi
    Hagihara, Atsushi
    Yamamoto, Akira
    Fujii, Hideki
    Tanaka, Shogo
    Enomoto, Masaru
    Tamori, Akihiro
    Miki, Yukio
    Kubo, Shoji
    Kawada, Norifumi
    JGH OPEN, 2022, 6 (11): : 754 - 762
  • [7] A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization
    Lladó, L
    Virgili, J
    Figueras, J
    Valls, C
    Dominguez, J
    Rafecas, A
    Torras, J
    Fabregat, J
    Guardiola, J
    Jaurrieta, E
    CANCER, 2000, 88 (01) : 50 - 57
  • [8] Development and validation of a deep learning model for survival prognosis of transcatheter arterial chemoembolization in patients with intermediate-stage hepatocellular carcinoma
    Wang, Hairui
    Liu, Yuchan
    Xu, Nan
    Sun, Yuanyuan
    Fu, Shihan
    Wu, Yunuo
    Liu, Chunhe
    Cui, Lei
    Liu, Zhaoyu
    Chang, Zhihui
    Li, Shu
    Deng, Kexue
    Song, Jiangdian
    EUROPEAN JOURNAL OF RADIOLOGY, 2022, 156
  • [9] Transcatheter Arterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Clinical Outcome and Safety in Elderly Patients
    Nishikawa, Hiroki
    Kita, Ryuichi
    Kimura, Toru
    Ohara, Yoshiaki
    Takeda, Haruhiko
    Sakamoto, Azusa
    Saito, Sumio
    Nishijima, Norihiro
    Nasu, Akihiro
    Komekado, Hideyuki
    Osaki, Yukio
    JOURNAL OF CANCER, 2014, 5 (07): : 590 - 597
  • [10] Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma
    Arizumi, Tadaaki
    Ueshima, Kazuomi
    Minami, Tomohiro
    Kono, Masashi
    Chishina, Hirokazu
    Takita, Masahiro
    Kitai, Satoshi
    Inoue, Tatsuo
    Yada, Norihisa
    Hagiwara, Satoru
    Minami, Yasunori
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kudo, Masatoshi
    LIVER CANCER, 2015, 4 (04) : 253 - 262
12345